Issue link: https://viewer.e-digitaledition.com/i/802686
INTERFERON One of our labs has discovered that cells with the extra chromosome appear to feel they are under attack by bacteria or viruses even when they are not. The researchers even showed why this is so. They induce something called the interferon response, a natural response our cells have to combat infection. In cells of typical people, interferon response is activated only when needed, because chronic activation is capable of causing damage. This is exactly what is happening in Down syndrome cells, and it may be responsible for much of the negative medical and cognitive effects associated with Down syndrome. For example, the interferon response, when over-activated, is capable of causing autoimmune responses. It also induces inflammation in the brain. Why does the extra chromosome cause this inappropriate interferon induction? One theory is that four of the proteins needed for interferon response are encoded by genes on chromosome 21. If those proteins are made at a higher level due to the extra chromosome, they would be expected to result in inappropriate and chronic interferon induction. There are interferon-related, FDA-approved drugs already being tested for autoimmune diseases that could be evaluated to see if they have positive effects on people with Down syndrome. Testing these ideas is already under way. STEM CELLS Most cells in the adult body don't divide to form new cells, but some do. These are called stem cells, and they are responsible for producing all the cells the body needs during development and growth, as well as for replenishing damaged cells during adult life. Stem cells are also thought to be responsible for cancer, which is essentially uncontrolled cell division. Do people with Down syndrome have a problem with stem cells? We have several labs working to answer this question, as there is good reason to believe the answer might be "yes." The brain of a person with Down syndrome has fewer nerve cells than a typical person, and cultured cells with the extra chromosome divide more slowly. In addition, in people with Down syndrome, solid tumor cancers are rare. One of our labs has been studying the function of stem cells in muscle healing following injury for years, and the researchers decided to find out whether mice with an extra chromosome containing genes found on human chromosome 21 have a problem CONTINUED FROM PAGE 9 with wound healing that depends on stem cells. They found that muscle stem cells with an extra chromosome are clearly defective in wound healing. However, these cells don't die. They remain inactive in the mouse when they should be dividing. This project has provided the strongest evidence yet that a central problem children and adults with Down syndrome may have is underachieving stem cells. If this is the case, we already know of ways in which their activity could be boosted. BLOOD PROTEINS Another group of scientists is studying the blood of people with Down syndrome to uncover any potentially new information about whether protein changes accompany particular symptoms of Down syndrome. Remarkably, these scientists have found that proteins that instruct cells to perform certain tasks are increased or decreased in the blood of people with Down syndrome. The majority of these proteins are implicated in immune system function, and this finding may relate to research conducted by the lab that discovered chronic interferon signaling. Furthermore, these altered signaling molecules could explain the scientists' result related to stem cell failure. MEANINGFUL COLLABORATION There are many other areas of research in which the Crnic Institute excels, including the numerous labs we have working on Alzheimer's disease. However, these three examples show how several seemingly disparate projects are, in fact, all related to each other. This comes from our creation of the Crnic Institute as a community of researchers, all focused on understanding the molecular biology and genetics of Down syndrome and all committed to improving the lives of those with Down syndrome. The beauty of our work is that nearly everyone can benefit from Down syndrome research. Knowing we can not only improve health outcomes for people with Down syndrome, but also contribute to a cure for Alzheimer's disease creates such a meaningful and dedicated working environment. Of course, none of this would be possible without our affiliate the Global Down Syndrome Foundation and our amazing individuals with Down syndrome and their families. Personally, I am proud to be able to contribute to and be part of this wonderful community. WINTER2017 DOWN SYNDROME WORLD 10

